findmyKOL
Clinical trialNCT07694986RecruitingPhase 2Interventional

Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment30Breast CancerLeptomeningeal Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to learn about the effects of the study treatment, Dendritic Cell Vaccine (DCV), in combination with trastuzumab or nivolumab to confirm the highest dose of the study treatment that can be given safely to participants with Breast Cancer (BC) with Leptomeningeal Disease (LMD).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Aixa Soyano Muller, MDAlisha Fell, ARNPAndre Beer Furlan, MDArnold Etame, MDBrian Czerniecki, MDHien Liu, MDHyo Han, MDJames Liu, MDJoaquim Farinhas, MDKamran Ahmed, MDMichael Vogelbaum, MDMichael Yu, MDNam Tran, MDPatrick Grogan, MDPeter Forsyth, MDSepideh Mokhtari, MDYolanda Pina, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Nivolumab →Trastuzumab →CDC1 Vaccine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2026
Primary completion
31 Aug 2029
Completion
31 Aug 2030
Last update posted
10 Jul 2026
Registered enrollment
30
Registry id
NCT07694986
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.